A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

IsraelRecruiting

Conditions

Recurrent Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Banner Health MD Anderson Phoenix, Gilbert, Arizona, United States
Contact: Study coordinator (Michael Samuels, MD) · michael.samuels2@bannerhealth.com · 305-213-8550
Contact: Study coordinator (Pamela Urban) · Pamela.Urban@bannerhealth.com
Dignity Health Cancer Institute, Phoenix, Arizona, United States
Alliance Dermatology, Phoenix, Arizona, United States
Contact: Study coordinator (Sadra Sasha Jazayeri, MD) · drjaz99@yahoo.com · 602-971-0268
Contact: Study coordinator (Michelle Ogden) · michelle@alliancedermatology.com · 602-971-0268
UCLA, Los Angeles, California, United States
Contact: Study coordinator (Albert Chang, MD) · ajchang@mednet.ucla.edu · 617-935-9275
Contact: Study coordinator (Jackie Hernandez) · JHernandez@mednet.ucla.edu · 310-267-8991
Day Star Skin and Cancer Center, DeLand, Florida, United States
Contact: Study coordinator (Neil Sandhu, MD) · nsandhu@annexusderm.com · 868-628-3376
Contact: Study coordinator (Angie Galicia) · agalicia@annexusderm.com · 13866283376
Integrity Research Clinical Associates, Delray Beach, Florida, United States
Contact: Study coordinator (John Strasswimmer, MD) · strasswimmer@gmail.com
Contact: Study coordinator (Puente Renzo) · rpuente@integriresearch.com · (561)654-0462
Palm beach Dermatology Group, Delray Beach, Florida, United States
Contact: Study coordinator (Adam Plotkin, MD) · adam@adamplotkin.com · 561-270-3928
Contact: Study coordinator (Samantha Ayoub) · sammy@adamplotkin.com · (561) 5591516
Hollywood Dermatology, Hollywood, Florida, United States
Contact: Study coordinator (Eduardo T Weiss, MD) · EWeissSCR@gmail.com · 561-958-3116
Contact: Study coordinator (Lori R Apteker) · laptekar@dermcaremgt.com · 561-948-3116
University of Miami, Miami, Florida, United States
Contact: Study coordinator (Matthew Abramowitz, MD) · mabramowitz@med.miami.edu · 305-781-6555
Contact: Study coordinator (Zuzel Rodrigues) · z.rodriguez1@med.miami.edu · +13052430124
Baptist Health South Florida MCI, Miami, Florida, United States
Contact: Study coordinator (Noah S Kalman, MD) · noahk@baptisthealth.net · 203-645-0185
Moffitt Cancer Center, Tampa, Florida, United States
Beer Dermatology, West Palm Beach, Florida, United States
Contact: Study coordinator (Beer Kenneth, MD) · kenbeer@aol.com · 561-655-9055
Contact: Study coordinator (Monica Dunn) · mdunn@beerdermatology.com
Emory University, Atlanta, Georgia, United States
Contact: Study coordinator (Zachary Buchwald, MD) · Zbuchwa@emory.edu
Contact: Study coordinator (Stacie Hitchcook) · stitch2@emory.edu
Mayo Clinic Rochester, Rochester, Minnesota, United States
Contact: Study coordinator (Timothy Malouff, MD) · Malouff.Timothy@mayo.edu · 215-990-6189
Schweiger Dermatology Group, Hackensack, New Jersey, United States
Contact: Study coordinator (David Goldberg, MD) · david.goldberg@schweigerderm.com · 609-219-5621
Contact: Study coordinator (Diana Aranzazu) · Diana.Aranzazu@schweigerderm.com · 201-951-0701
New Mexico Cancer Center, Albuquerque, New Mexico, United States
Contact: Study coordinator (Gregg E.Franklin, MD) · greggef@nmohc.com · 505-235-7245
Contact: Study coordinator (Sarah Tellez) · saraht@nmohc.com · (505)8144923
Bassett Healthcare Network, Cooperstown, New York, United States
Contact: Study coordinator (Timothy Korytko, MD) · timothy.korytko@bassett.org · 607-547-3089
Contact: Study coordinator (Peggy Cross) · peggy.cross@bassett.org
Northwell Health, Queens, New York, United States
New York Medical Skin Solutions, Rockaway Park, New York, United States
Contact: Study coordinator (Ritu Saini, MD) · r.saini@gen1research.com · 512-717-8610
MDCS Dermatology, Smithtown, New York, United States
Contact: Study coordinator (Snehal Amin, MD) · snehalmdcs@gmail.com
West Cancer Center, Germantown, Tennessee, United States
Gulf Coast Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Alpesh Desai, MD) · drdesai911@yahoo.com
Contact: Study coordinator (Mary Brown) · MBrown@gulfcoastcc.com · 7132560425
University Cancer & Diagnostic Center, Houston, Texas, United States
Contact: Study coordinator (Mark D'Andrea, MD) · mmmeead@aol.com · 713-474-1414
Contact: Study coordinator (Jo Ann Ramirez) · jramirez@gulfcoastcc.com · 713-474-1414
University of Virginia Health System, Charlottesville, Virginia, United States
Dermatology of Seattle and Bellevue, Bellevue, Washington, United States
Contact: Study coordinator (Elie Levy, MD) · elevy@dermatologyseattle.com · 425-455-5111
Princess Margaret Cancer Center, Toronto, Ontario, Canada
Contact: Study coordinator (Philip Wong, MD) · philip.wong@rmp.uhn.ca · +14168898710
Contact: Study coordinator (Elizabeth Evans) · elizabeth.evans@rmp.uhn.ca · (613)403-2188
Rambam Medical Center, Haifa, Israel
Contact: Study coordinator (Tomer Charas, MD) · t_charas@rambam.health.gov.il · +972502062073
Hadassah Medical Center, Jerusalem, Israel
Contact: Study coordinator (Aron Popovtzer, MD) · aron@hadassah.org.il · 972-2-6776709
Belinson-Rabin Medical Center, Petah Tikva, Israel
Contact: Study coordinator (Elisha Fredman, MD) · elishafre@clalit.org.il · +972-538299243
Sheba Medical Center, Ramat Gan, Israel
Contact: Study coordinator (Iris Gluck, MD) · iris.gluck@sheba.health.gov.il · +97252-6669142
Contact: Study coordinator (Shlomit Shamir Druskin) · Shlomit.ShamirDruskin@sheba.health.gov.il · 0507327830

View source on ClinicalTrials.gov Contact study team (email)